Laprophan, a Mediterrania Capital Partners portfolio company, acquires Rivopharm to accelerate its international expansion

by Mediterrania Capital Partners

The acquisition represents a transformational milestone in Laprophan's development and marks the Group's first acquisition in Europe. The transaction significantly strengthens Laprophan's European foo...

Read more

Laprophan, a Mediterrania Capital Partners' portfolio company, announces acquisition of Botanic Pharma

by Mediterrania Capital Partners

Laprophan, a Mediterrania Capital Partners' portfolio company, and a major player in the pharmaceutical sector in Africa and the Middle East, has announced the acquisition of a majority stake in Botan...

Read more

Mediterrania Capital Partners, DEG, Proparco and FMO invest €75 million in Laprophan, one of the leading pharmaceutical companies in Morocco

by Mediterrania Capital Partners

Mediterrania Capital Partners is pleased to announce its acquisition of a stake in Laprophan – one of the leading pharmaceutical companies in Morocco –through its fund MC IV, alongside Germany’s...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Xcalibur Smart Mapping strengthens its g...

by MCH Private Equity

​Xcalibur Smart Mapping, recognised as the global leader in airborne...

Photos Stream